DPT Laboratories (Confab — Canada)
Saint-Hubert, QC, Canada
Program data pending ClinicalTrials.gov matching
78.7
Signal Score
✓ FDA Inspections (1)
○ Clinical Trials
○ SEC Filings
✓ Press (5)
○ EMA GMP
○ MHRA GMP
Quick Facts: DPT Laboratories (Confab — Canada)
- Signal Score
- 78.7/100
- Quality Compliance
- 100.0/100
- Headquarters
- Saint-Hubert, QC, Canada
- Modalities
- Semi-solids (creams, gels, ointments), Oral solid dose, Non-sterile liquids, Suppositories
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About DPT Laboratories (Confab — Canada)
Auto-created by AI matchmaker. Data verification pending.
Signal Score & Pillar Breakdown
Quality Compliance
100.0
FDA Inspections1 on record
Warning Letters0
Last InspectionNo Action Indicated (NAI) (2025-05-06)
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesSemi-solids (creams, gels, ointments), Oral solid dose, Non-sterile liquids, Suppositories
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
60.0
Broad modality coverage (4 modalities)
Source: SEC EDGAR, press monitoring, company profiles
Profile-based capacity assessment
Recent Press5 articles
Broad modality coverage (4 modalities)
DPT Laboratories (Confab — Canada) FDA Inspection History
2025-05
NAI
VAI
OAI
| Date | Site | Type | Observations | Classification |
|---|---|---|---|---|
| 2025-05-06 | San Antonio, Texas | Drug Quality Assurance | No | No Action Indicated (NAI) |
Source: FDA Data Dashboard · Retrieved Jul 17, 2026
Recent News 5 articles
DPT Laboratories names Kuljit Bhatia Vice President of Research & Development - Contract Pharma
CEO Insights: Industry Trends Driving Strong Tailwinds for U.S.-based CDMOs - Contract Pharma
CEO Spotlight: Paul Josephs - Contract Pharma
Semi-Solid Dosage Contract Manufacturing Market Size to Hit USD 61.81 Bn by 2035 - Precedence Research
Mylan gets topicals CDMO as part of $1B deal for skin products - Fierce Pharma
Frequently Asked Questions About DPT Laboratories (Confab — Canada)
How many FDA inspections does DPT Laboratories (Confab — Canada) have on record?
CDMO Signal tracks 1 FDA inspection for DPT Laboratories (Confab — Canada), sourced from the FDA inspection database. See the full inspection history above.
Has DPT Laboratories (Confab — Canada) received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for DPT Laboratories (Confab — Canada).
What is DPT Laboratories (Confab — Canada)'s CDMO Signal Score?
DPT Laboratories (Confab — Canada) has a Signal Score of 79/100, based on quality, operations, financial stability, and capacity data.
Evaluating DPT Laboratories (Confab — Canada) for a manufacturing program?
Use the free AI matchmaker to compare DPT Laboratories (Confab — Canada) against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.